21 C.F.R. § 862.1245

Dehydroepiandrosterone (free and sulfate) test system.

Last amended: 2016Year: 2026Length: 83 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1245 (2026)

(a) Identification. A dehydroepiandrosterone (free and sulfate) test system is a device intended to measure dehydroepiandrosterone (DHEA) and its sulfate in urine, serum, plasma, and amniotic fluid. Dehydroepiandrosterone measurements are used in the diagnosis and treatment of DHEA-secreting adrenal carcinomas. (b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. [52 FR 16122, May 1, 1987, as amended at 65 FR 2306, Jan. 14, 2000]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1245: Dehydroepiandrosterone (free and sulfate) test system. | Justis AI